Two Sigma Investments’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Buy |
55,739
+412
| +0.7% | +$1.58K | ﹤0.01% | 2850 |
|
|
2025
Q1 | $318K | Sell |
55,327
-76,083
| -58% | -$437K | ﹤0.01% | 2630 |
|
|
2024
Q4 | $656K | Sell |
131,410
-15,349
| -10% | -$76.6K | ﹤0.01% | 2344 |
|
|
2024
Q3 | $791K | Sell |
146,759
-46,356
| -24% | -$250K | ﹤0.01% | 2188 |
|
|
2024
Q2 | $639K | Sell |
193,115
-45,849
| -19% | -$152K | ﹤0.01% | 2168 |
|
|
2024
Q1 | $781K | Buy |
238,964
+37,423
| +19% | +$122K | ﹤0.01% | 2043 |
|
|
2023
Q4 | $707K | Sell |
201,541
-65,781
| -25% | -$231K | ﹤0.01% | 2199 |
|
|
2023
Q3 | $1.79M | Buy |
267,322
+136,022
| +104% | +$909K | ﹤0.01% | 1416 |
|
|
2023
Q2 | $1.1M | Sell |
131,300
-89,200
| -40% | -$748K | ﹤0.01% | 1826 |
|
|
2023
Q1 | $2.19M | Sell |
220,500
-230,187
| -51% | -$2.29M | 0.01% | 1269 |
|
|
2022
Q4 | $3.14M | Sell |
450,687
-130,752
| -22% | -$910K | 0.01% | 1047 |
|
|
2022
Q3 | $3.11M | Sell |
581,439
-24,629
| -4% | -$132K | 0.01% | 929 |
|
|
2022
Q2 | $2.42M | Buy |
606,068
+263,181
| +77% | +$1.05M | 0.01% | 1054 |
|
|
2022
Q1 | $1.52M | Sell |
342,887
-334,185
| -49% | -$1.49M | ﹤0.01% | 1447 |
|
|
2021
Q4 | $2.71M | Sell |
677,072
-119,153
| -15% | -$477K | 0.01% | 1189 |
|
|
2021
Q3 | $6.99M | Sell |
796,225
-334,509
| -30% | -$2.94M | 0.02% | 736 |
|
|
2021
Q2 | $12.8M | Buy |
1,130,734
+248,772
| +28% | +$2.82M | 0.03% | 562 |
|
|
2021
Q1 | $10.5M | Buy |
881,962
+215,593
| +32% | +$2.56M | 0.03% | 567 |
|
|
2020
Q4 | $4.57M | Sell |
666,369
-3,465
| -0.5% | -$23.8K | 0.01% | 775 |
|
|
2020
Q3 | $4.96M | Buy |
669,834
+496,101
| +286% | +$3.68M | 0.02% | 611 |
|
|
2020
Q2 | $724K | Buy |
173,733
+95,173
| +121% | +$397K | ﹤0.01% | 1279 |
|
|
2020
Q1 | $194K | Buy |
+78,560
| New | +$194K | ﹤0.01% | 1609 |
|
|
2018
Q4 | – | Sell |
-40,929
| Closed | -$565K | – | 2057 |
|
|
2018
Q3 | $565K | Buy |
+40,929
| New | +$565K | ﹤0.01% | 1557 |
|